A recent study has demonstrated that PD-1 monotherapy (e.g., B16 melanoma and MC38 colon cancer models) directly activate microglia, and ablating microglia was sufficient to rescue αPD-1-mediated cognitive deficits [58]. This evidence concerns the gene PDCD1 and malignant colon neoplasm.